Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 2009

View Archived Issues

GPR3 identified as a new pharmacological target for Alzheimer's disease

Coeloglossum viride extract protective in models of brain ischemia

Mechanism of action, activity of the coumarin scopoletin described

Meditor concludes merger agreement with American Medical Technologies

Protalix BioTherapeutics receives research grant from the Israeli government

FDA accepts for review Endo's complete response submission to NDA for Nebido

Novel MC4 receptor agonists prepared and tested at Santhera

Metabolex patents novel glucose-dependent insulinotropic receptor agonists

Janssen Pharmaceutica claims novel cannabinoid modulators

Biothera receives approval to launch two phase II lung cancer trials

Alimera reports 12-month interim safety and efficacy results for Iluvien

ReGen reports first findings from Colostrinin peptide studies

Auris Medical initiates phase IIb AM-101 trial in acute inner ear tinnitus

Novel matrix metalloprotease inhibitor shows efficacy in lung inflammation in vivo

T-115 shows potent antitumor activity in vitro and in vivo

BioCis Pharma commences phase IIa testing for ProtoCure in psoriasis

Dainippon launches Trerief in Japan for Parkinson's disease

Renovo reports phase II results for Juvidex

Oncolytics initiates patient enrollment in phase II trial of Reolysin in NSCLC

Vertex Pharmaceuticals acquires ViroChem Pharma

Nippon Chemiphar presents novel P2X4 receptor antagonists

Yakult Honsha claims novel gamma-secretase inhibitors

Edluar receives FDA approval for insomnia

Medivir: fourth quarter in brief

YM BioSciences enrolls first patient into multinational nimotuzumab trial in NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...